A 31-year-old woman presents with a diffuse, painful erythematous rash on her left lower leg that developed over 12 hours. She has a temperature of 38.7°C and feels generally unwell. On examination, the affected area is bright red, well-demarcated, raised above surrounding skin, and has an 'orange peel' appearance. There is associated tender inguinal lymphadenopathy. She reports having had similar episodes twice before in the same location. What is the most important prophylactic measure to discuss with this patient?
Q202
A 64-year-old woman with recurrent MRSA skin and soft tissue infections has undergone three successful decolonization attempts over the past year, but surveillance swabs consistently become positive again within 3 months. She lives with her husband who has chronic leg ulcers, and they have two dogs that sleep in their bedroom. Despite adherence to decolonization protocols, she develops another MRSA abscess requiring drainage. Which management strategy represents the most evidence-based approach to prevent future recurrence?
Q203
A hospital trust implements a quality improvement initiative requiring antimicrobial prescriptions to include documentation of: indication, drug choice, dose, route, duration, and review date. Six months after implementation, audit shows 78% compliance for indication, 81% for drug/dose/route, but only 42% for review date and 38% for intended duration. Antimicrobial consumption has not decreased. Which additional intervention would most effectively improve outcomes and reduce inappropriate antimicrobial use?
Q204
A 39-year-old man who injects performance-enhancing drugs presents with a 5-day history of severe pain in his left thigh with fever and malaise. Examination reveals a tense, swollen thigh with woody induration, purple discolouration of overlying skin, and multiple small areas of necrosis. Crepitus is present. He is tachycardic (128 bpm), hypotensive (88/52 mmHg), and has acute kidney injury (creatinine 298 μmol/L from baseline 76 μmol/L). CT shows extensive gas within muscle compartments. Which statement best describes the optimal management approach?
Q205
A hospital antimicrobial stewardship team reviews prescribing data and identifies that 35% of patients receiving carbapenems for Gram-negative infections have organisms that are susceptible to narrower-spectrum agents such as piperacillin-tazobactam or third-generation cephalosporins. Despite availability of culture results showing susceptibility patterns, prescribers continue broad-spectrum therapy. Which antimicrobial stewardship intervention would most effectively address this issue?
Q206
A 53-year-old man with end-stage renal failure on haemodialysis presents with fever, rigors, and hypotension. His tunnelled dialysis catheter exit site shows erythema and purulent discharge. Blood cultures are taken and he is started on empirical antibiotics. The next day, blood cultures grow coagulase-negative Staphylococcus with intermediate glycopeptide resistance (vancomycin MIC 4 mg/L). The catheter is essential for dialysis access. What is the most appropriate definitive management?
Q207
A 68-year-old man on a surgical ward develops hospital-acquired pneumonia and is started on IV piperacillin-tazobactam. After 3 days of treatment, sputum culture results become available showing Pseudomonas aeruginosa sensitive to piperacillin-tazobactam (MIC 8 mg/L), meropenem, gentamicin, and ciprofloxacin, but resistant to co-amoxiclav and ceftriaxone. The patient is clinically improving with decreasing oxygen requirements and falling inflammatory markers. According to antimicrobial stewardship principles, what is the most appropriate action?
Q208
A 42-year-old woman presents to A&E with a 2-day history of pain, swelling, and redness around a cat bite on her right hand sustained 48 hours ago. The wound was initially cleaned at home. On examination, the dorsum of the hand is swollen, erythematous, and tender with purulent discharge from the bite wound. She is apyrexial but has reduced range of movement in her fingers due to swelling. What is the most appropriate antibiotic choice?
Q209
A 51-year-old man with poorly controlled type 2 diabetes (HbA1c 96 mmol/mol) presents to the Emergency Department with a 3-day history of severe pain, swelling, and discharge from his right foot. Examination reveals a deep ulcer on the plantar surface with visible bone, surrounding erythema extending 5 cm from the wound edge, and purulent discharge. X-ray shows soft tissue gas and bony destruction. Temperature is 38.6°C, heart rate 104 bpm, and blood pressure 118/72 mmHg. What is the most appropriate initial antibiotic regimen?
Q210
A 29-year-old woman with no past medical history presents to her GP with a painful red lump on her inner thigh that has been present for 3 days. On examination, there is a 3 cm fluctuant, erythematous swelling with a central punctum. She is apyrexial with no signs of spreading infection. She asks if she needs antibiotics. What is the most appropriate initial management?
Common Infections UK Medical PG Practice Questions and MCQs
Question 201: A 31-year-old woman presents with a diffuse, painful erythematous rash on her left lower leg that developed over 12 hours. She has a temperature of 38.7°C and feels generally unwell. On examination, the affected area is bright red, well-demarcated, raised above surrounding skin, and has an 'orange peel' appearance. There is associated tender inguinal lymphadenopathy. She reports having had similar episodes twice before in the same location. What is the most important prophylactic measure to discuss with this patient?
A. Long-term prophylactic oral flucloxacillin 250 mg twice daily
C. Regular application of emollients to prevent skin fissuring
D. Compression stockings to improve venous drainage
E. Prophylactic benzathine penicillin injections every 3 weeks
Explanation: ***Long-term prophylactic oral phenoxymethylpenicillin 250-500 mg twice daily***- The patient presents with **erysipelas**, suggested by the **well-demarcated**, raised, bright red rash and **'peau d'orange'** appearance, typically caused by **Group A Streptococcus**.- Since she has had **two or more episodes** at the same site, long-term prophylaxis with **phenoxymethylpenicillin** is indicated to prevent further recurrence and potential **lymphedema**.*Long-term prophylactic oral flucloxacillin 250 mg twice daily*- **Flucloxacillin** is primarily used for its **anti-staphylococcal** activity; however, streptococci are the dominant cause of recurrent erysipelas.- **Phenoxymethylpenicillin** is preferred as a more targeted agent to prevent resistance and specifically cover **Streptococcus pyogenes**.*Regular application of emollients to prevent skin fissuring*- **Emollients** are important for maintaining **skin integrity** and preventing entry points for bacteria, but they are considered an **adjunctive measure**.- In the case of **recurrent infections** (2+ episodes), pharmacological prophylaxis with antibiotics takes priority over topical skin care alone.*Compression stockings to improve venous drainage*- **Compression therapy** can help manage underlying **venous insufficiency** or chronic edema which are risk factors, but it is not the primary treatment for preventing infection recurrence.- Use of stockings must be avoided during the **acute phase** of infection due to pain and the potential to worsen the inflammatory response.*Prophylactic benzathine penicillin injections every 3 weeks*- **Benzathine penicillin injections** are the standard of care for secondary prophylaxis of **Rheumatic Fever**, not for preventing soft tissue infections.- While effective against streptococci, **oral dosing** is the first-line and less invasive prophylactic strategy recommended for **recurrent cellulitis** or erysipelas.
Question 202: A 64-year-old woman with recurrent MRSA skin and soft tissue infections has undergone three successful decolonization attempts over the past year, but surveillance swabs consistently become positive again within 3 months. She lives with her husband who has chronic leg ulcers, and they have two dogs that sleep in their bedroom. Despite adherence to decolonization protocols, she develops another MRSA abscess requiring drainage. Which management strategy represents the most evidence-based approach to prevent future recurrence?
A. Extend decolonization regimen to 14 days and repeat monthly for 6 months
B. Perform environmental decontamination, screen and treat household contacts, and consider pet screening (Correct Answer)
C. Prescribe long-term suppressive oral doxycycline 100 mg daily
D. Implement twice-daily chlorhexidine body washes indefinitely
E. Arrange for immunological assessment for underlying immune deficiency
Explanation: ***Perform environmental decontamination, screen and treat household contacts, and consider pet screening***
- Recurrent **MRSA colonization** after successful decolonization, despite adherence to protocols, strongly indicates **re-exposure** from the immediate environment or close contacts.
- An evidence-based strategy involves simultaneously addressing potential reservoirs such as **household contacts** (especially those with chronic wounds like leg ulcers) and **pet screening**, alongside environmental cleaning to break the cycle of transmission.
*Extend decolonization regimen to 14 days and repeat monthly for 6 months*
- Prolonged use of topical decolonization agents, like **mupirocin**, significantly increases the risk of developing **antibiotic resistance** without addressing the underlying sources of reinfection.
- Standard 5-day decolonization protocols are generally effective; repeated failures usually point to **recolonization** from external reservoirs rather than insufficient duration.
*Prescribe long-term suppressive oral doxycycline 100 mg daily*
- **Long-term systemic antibiotic suppression** is not a standard or recommended strategy for MRSA decolonization due to concerns about the emergence of **multidrug-resistant organisms** and potential side effects.
- This approach does not eliminate the primary **colonization reservoir** on the patient's skin or nares, or within their household environment and contacts.
*Implement twice-daily chlorhexidine body washes indefinitely*
- While **chlorhexidine body washes** can effectively reduce skin colonization, they do not eradicate **nasal carriage**, which is a significant reservoir for MRSA.
- **Indefinite use** can lead to skin irritation or sensitization and, more importantly, does not address the crucial **environmental reservoirs** or colonized household contacts.
*Arrange for immunological assessment for underlying immune deficiency*
- While recurrent infections can sometimes indicate an underlying **immune deficiency**, the detailed history points strongly to **exogenous re-exposure** from identified risk factors (husband's ulcers, pets).
- Immunological testing should generally be considered only after **environmental and household transmission factors** have been thoroughly controlled and recurrent infections persist.
Question 203: A hospital trust implements a quality improvement initiative requiring antimicrobial prescriptions to include documentation of: indication, drug choice, dose, route, duration, and review date. Six months after implementation, audit shows 78% compliance for indication, 81% for drug/dose/route, but only 42% for review date and 38% for intended duration. Antimicrobial consumption has not decreased. Which additional intervention would most effectively improve outcomes and reduce inappropriate antimicrobial use?
A. Introduce mandatory 48-72 hour antimicrobial prescribing review by senior clinician (Correct Answer)
B. Implement electronic prescribing system alerts for missing documentation fields
C. Increase frequency of audit and feedback cycles to monthly intervals
D. Provide individual feedback to prescribers with lowest compliance rates
E. Develop antimicrobial prescribing competency framework for junior doctors
Explanation: ***Introduce mandatory 48-72 hour antimicrobial prescribing review by senior clinician***
- The **Start Smart – Then Focus** framework emphasizes that the **48-72 hour review** is the most critical intervention for deciding to stop, switch, or de-escalate antimicrobial therapy.
- Since antimicrobial consumption did not decrease despite some documentation improvements, a **mandatory senior review** ensures timely clinical action to reduce inappropriate or prolonged use, rather than just administrative compliance.
*Implement electronic prescribing system alerts for missing documentation fields*
- While alerts can improve **documentation compliance** rates for fields like review date and duration, they do not guarantee appropriate clinical decision-making or the subsequent action to stop or de-escalate.
- This intervention primarily addresses the **symptom of incomplete record-keeping** rather than the underlying clinical issue of continued inappropriate antimicrobial use.
*Increase frequency of audit and feedback cycles to monthly intervals*
- **Audit and feedback** are valuable tools for monitoring trends and identifying areas for improvement, but increasing their frequency alone does not provide a direct, real-time clinical intervention to stop unnecessary treatments.
- Monthly cycles still involve a **time lag** that may not influence the immediate management of a patient currently on antibiotics, thus failing to promptly reduce consumption.
*Provide individual feedback to prescribers with lowest compliance rates*
- Targeted feedback can address **behavioral outliers** or specific knowledge gaps but does not implement a systemic process for proactive clinical review at the crucial 48-72 hour mark.
- This approach focuses on **retrospective accountability** rather than the prospective, active stewardship required to change prescribing decisions in real-time and reduce overall consumption.
*Develop antimicrobial prescribing competency framework for junior doctors*
- Education and **competency frameworks** are crucial for building foundational knowledge and skills for long-term improvement in prescribing practices.
- However, they often lack the immediate impact needed to change existing prescribing patterns or ensure timely de-escalation decisions, which frequently require **senior oversight** and institutional policy enforcement.
Question 204: A 39-year-old man who injects performance-enhancing drugs presents with a 5-day history of severe pain in his left thigh with fever and malaise. Examination reveals a tense, swollen thigh with woody induration, purple discolouration of overlying skin, and multiple small areas of necrosis. Crepitus is present. He is tachycardic (128 bpm), hypotensive (88/52 mmHg), and has acute kidney injury (creatinine 298 μmol/L from baseline 76 μmol/L). CT shows extensive gas within muscle compartments. Which statement best describes the optimal management approach?
A. Urgent surgical debridement combined with IV benzylpenicillin and clindamycin (Correct Answer)
B. IV piperacillin-tazobactam monotherapy with 24-hour surgical review
C. Hyperbaric oxygen therapy as primary treatment with delayed surgery
D. IV vancomycin and meropenem pending blood culture results
E. Immediate fasciotomy followed by IV flucloxacillin and metronidazole
Explanation: ***Urgent surgical debridement combined with IV benzylpenicillin and clindamycin***- The patient's presentation with **crepitus**, **woody induration**, **purple discoloration**, **necrosis**, and **gas in muscle compartments** in an intravenous drug user is highly suggestive of **clostridial myonecrosis** (gas gangrene).- **Urgent surgical debridement** is critical for source control and removal of necrotic tissue, while **benzylpenicillin** targets *Clostridium perfringens* and **clindamycin** provides an essential **antitoxin effect**, inhibiting bacterial protein synthesis and toxin production.*IV piperacillin-tazobactam monotherapy with 24-hour surgical review*- A 24-hour delay for surgical review is unacceptable in **gas gangrene**, which is a rapidly progressive, life-threatening emergency requiring **immediate surgical intervention**.- While piperacillin-tazobactam has broad-spectrum activity, it lacks the specific **antitoxin effect** of clindamycin, which is crucial for managing the severe systemic toxicity of clostridial infections.*Hyperbaric oxygen therapy as primary treatment with delayed surgery*- **Hyperbaric oxygen therapy** (HBO) can be a useful *adjunctive* treatment by inhibiting toxin production and bacterial growth in anaerobic conditions, but it is **not a primary treatment** and should never delay urgent surgical debridement.- The priority in **necrotizing soft tissue infections** is the immediate removal of necrotic tissue and source control, which only surgery can achieve.*IV vancomycin and meropenem pending blood culture results*- This regimen is broad but may not be optimal for *Clostridium perfringens*, and more importantly, **waiting for blood culture results** is dangerously delayed given the patient's presentation of **septic shock** and rapidly progressing infection.- **Empiric antibiotic therapy** for necrotizing soft tissue infection must be initiated immediately, targeting likely pathogens including anaerobes.*Immediate fasciotomy followed by IV flucloxacillin and metronidazole*- **Fasciotomy** primarily addresses compartment syndrome by relieving pressure; however, in **myonecrosis**, the muscle itself is necrotic, requiring **extensive surgical debridement** or amputation, not just incision of the fascia.- **Flucloxacillin** primarily covers Staphylococcus, which is not the main pathogen for gas gangrene, and while metronidazole covers anaerobes, it lacks the specific **antitoxin effect** of clindamycin.
Question 205: A hospital antimicrobial stewardship team reviews prescribing data and identifies that 35% of patients receiving carbapenems for Gram-negative infections have organisms that are susceptible to narrower-spectrum agents such as piperacillin-tazobactam or third-generation cephalosporins. Despite availability of culture results showing susceptibility patterns, prescribers continue broad-spectrum therapy. Which antimicrobial stewardship intervention would most effectively address this issue?
A. Implement automatic stop dates for all carbapenem prescriptions after 72 hours
B. Introduce mandatory infectious diseases consultation for all carbapenem prescriptions
C. Develop an automatic de-escalation alert system triggered by culture sensitivities (Correct Answer)
D. Restrict carbapenem prescribing to consultant-level authorization only
E. Provide annual antimicrobial stewardship training to all prescribers
Explanation: ***Develop an automatic de-escalation alert system triggered by culture sensitivities***- This intervention directly targets the specific problem identified by providing **real-time, point-of-care decision support** when culture results become available.- **De-escalation** is a core antimicrobial stewardship principle that reduces the selection pressure for **multi-drug resistant organisms** while maintaining clinical efficacy.*Implement automatic stop dates for all carbapenem prescriptions after 72 hours*- While **automatic stop dates** encourage the review of therapy, they do not provide specific guidance on which **narrower-spectrum agent** to switch to based on results.- This approach carries a risk of **treatment gaps** if the prescriber is busy and fails to manually re-order or adjust the antibiotic promptly.*Introduce mandatory infectious diseases consultation for all carbapenem prescriptions*- Mandatory consultations are highly effective but are **resource-intensive** and may cause significant delays in starting or adjusting therapy in a large hospital setting.- This intervention is often reserved for complex infections like **Staphylococcus aureus bacteremia** rather than routine de-escalation based on simple susceptibility.*Restrict carbapenem prescribing to consultant-level authorization only*- **Restrictive authorization** (front-end stewardship) primarily controls the initial empirical use of broad-spectrum drugs rather than the **back-end de-escalation** process.- It does not address the behavioral issue where clinicians continue broad-spectrum therapy even after meeting the criteria for **narrow-spectrum alternatives**.*Provide annual antimicrobial stewardship training to all prescribers*- **Educational interventions** are considered "passive" and are generally less effective at changing physician behavior compared to "active" clinical decision support systems.- Training lacks the **immediacy** required to prompt action at the specific moment a culture result is published and a decision needs to be made.
Question 206: A 53-year-old man with end-stage renal failure on haemodialysis presents with fever, rigors, and hypotension. His tunnelled dialysis catheter exit site shows erythema and purulent discharge. Blood cultures are taken and he is started on empirical antibiotics. The next day, blood cultures grow coagulase-negative Staphylococcus with intermediate glycopeptide resistance (vancomycin MIC 4 mg/L). The catheter is essential for dialysis access. What is the most appropriate definitive management?
A. Continue vancomycin and treat through the catheter for 14 days
B. Remove the catheter and treat with daptomycin for 14 days (Correct Answer)
C. Treat with linezolid orally for 14 days while retaining the catheter
D. Antibiotic lock therapy with vancomycin plus systemic gentamicin
E. Remove the catheter and treat with high-dose vancomycin for 6 weeks
Explanation: ***Remove the catheter and treat with daptomycin for 14 days*** - **Catheter removal** is mandatory due to **sepsis** (fever, rigors, hypotension) and local infection, indicating the catheter is the source and **source control** is critical. - **Daptomycin** is the appropriate bactericidal agent for treating bloodstream infections with **coagulase-negative Staphylococcus** that show **intermediate glycopeptide resistance** (vancomycin MIC 4 mg/L), as vancomycin is likely ineffective. *Continue vancomycin and treat through the catheter for 14 days* - Continuing **vancomycin** is inappropriate because an **MIC of 4 mg/L** indicates intermediate resistance, making clinical failure highly probable, especially in a severe infection. - Attempting to "treat through" a **tunneled catheter** is contraindicated in the presence of severe sepsis, hypotension, and purulent discharge at the exit site. *Treat with linezolid orally for 14 days while retaining the catheter* - **Linezolid** is generally bacteriostatic, and for severe **catheter-related bloodstream infections** with systemic signs, a bactericidal agent like daptomycin is often preferred. - **Retaining the catheter** prevents source control, which is essential for managing sepsis from an infected device, significantly increasing the risk of treatment failure and complications. *Antibiotic lock therapy with vancomycin plus systemic gentamicin* - **Antibiotic lock therapy** is typically reserved for uncomplicated infections where catheter salvage is attempted and is unsuitable for patients with **systemic instability** or purulent exit site infection. - The elevated **vancomycin MIC** makes vancomycin an ineffective choice for the lock, and systemic **gentamicin** carries a high risk of **ototoxicity** and nephrotoxicity in hemodialysis patients. *Remove the catheter and treat with high-dose vancomycin for 6 weeks* - High-dose **vancomycin** is unlikely to overcome an **MIC of 4 mg/L** and carries increased risk of toxicity without significantly improved efficacy against intermediate strains. - A **6-week duration** of antibiotics is excessive for an uncomplicated catheter-related bloodstream infection once the source is removed; it is reserved for complications like endocarditis or osteomyelitis.
Question 207: A 68-year-old man on a surgical ward develops hospital-acquired pneumonia and is started on IV piperacillin-tazobactam. After 3 days of treatment, sputum culture results become available showing Pseudomonas aeruginosa sensitive to piperacillin-tazobactam (MIC 8 mg/L), meropenem, gentamicin, and ciprofloxacin, but resistant to co-amoxiclav and ceftriaxone. The patient is clinically improving with decreasing oxygen requirements and falling inflammatory markers. According to antimicrobial stewardship principles, what is the most appropriate action?
A. Continue current therapy with piperacillin-tazobactam (Correct Answer)
B. Switch to meropenem as it has better pseudomonal activity
C. Switch to oral ciprofloxacin to facilitate earlier discharge
D. Add gentamicin to piperacillin-tazobactam for synergistic effect
E. Stop antibiotics as the patient is clinically improving
Explanation: ***Continue current therapy with piperacillin-tazobactam***
- The patient is showing **clinical improvement** and the organism is confirmed as **susceptible** to the current regimen, fulfilling core antimicrobial stewardship goals.
- **Piperacillin-tazobactam** is a narrow-spectrum choice relative to carbapenems, and continuing it prevents unnecessary use of broader-spectrum agents.
*Switch to meropenem as it has better pseudomonal activity*
- **Meropenem** is a carbapenem that should be **reserved** for multi-drug resistant organisms or patients failing first-line therapy to prevent the development of resistance.
- Escalating therapy when the patient is already improving on a susceptible agent violates **stewardship principles**.
*Switch to oral ciprofloxacin to facilitate earlier discharge*
- While **IV-to-oral switch** is a stewardship goal, it is premature as the patient still has **oxygen requirements**, indicating he is not yet stable for discharge.
- Ciprofloxacin is a potent **fluoroquinolone** and its premature use can drive resistance in *Pseudomonas* populations if the infection is not adequately controlled.
*Add gentamicin to piperacillin-tazobactam for synergistic effect*
- **Double coverage** for *Pseudomonas* is generally not recommended once sensitivities are known and the patient is showing signs of **clinical recovery**.
- Adding an **aminoglycoside** like gentamicin increases the risk of **nephrotoxicity** and ototoxicity without providing additional clinical benefit in this scenario.
*Stop antibiotics as the patient is clinically improving*
- Stopping therapy after only **3 days** for *Pseudomonas aeruginosa* pneumonia is inadequate; standard courses usually last **7 days** or more depending on severity.
- Premature cessation of antibiotics in a confirmed Gram-negative pneumonia carries a high risk of **relapse** and treatment failure.
Question 208: A 42-year-old woman presents to A&E with a 2-day history of pain, swelling, and redness around a cat bite on her right hand sustained 48 hours ago. The wound was initially cleaned at home. On examination, the dorsum of the hand is swollen, erythematous, and tender with purulent discharge from the bite wound. She is apyrexial but has reduced range of movement in her fingers due to swelling. What is the most appropriate antibiotic choice?
A. Flucloxacillin 500 mg four times daily
B. Co-amoxiclav 625 mg three times daily (Correct Answer)
C. Doxycycline 100 mg twice daily
D. Clarithromycin 500 mg twice daily
E. Metronidazole 400 mg three times daily
Explanation: ***Co-amoxiclav 625 mg three times daily***- This is the first-line treatment for **cat bites** as it provides broad-spectrum coverage against **Pasteurella multocida**, **Staphylococcus aureus**, and **anaerobes** found in feline oral flora.- It is highly effective in preventing and treating the rapid-onset cellulitis often seen with **Pasteurella**, which is a common pathogen in over 50% of cat bite infections.*Flucloxacillin 500 mg four times daily*- This antibiotic is excellent for typical skin infections caused by **Staphylococcus** or **Streptococcus** but lacks activity against **Pasteurella multocida**.- Using this alone in a cat bite scenario significantly increases the risk of treatment failure and progression to deep-tissue infection.*Doxycycline 100 mg twice daily*- While it has activity against **Pasteurella**, it is typically reserved as an alternative for patients with a **penicillin allergy**.- It has inferior efficacy compared to co-amoxiclav for the mixed aerobic and anaerobic populations common in animal bites.*Clarithromycin 500 mg twice daily*- This macrolide has variable and often inadequate activity against **Pasteurella multocida** and common oral anaerobes.- It is not recommended as a first-line or primary monotherapy for hand infections resulting from animal bites.*Metronidazole 400 mg three times daily*- This provides excellent coverage for **strict anaerobes** but has no activity against **aerobic organisms** like Pasteurella or Staphylococcus.- It must be used in combination with another agent (like doxycycline) if a penicillin allergy is present, but is inappropriate as monotherapy here.
Question 209: A 51-year-old man with poorly controlled type 2 diabetes (HbA1c 96 mmol/mol) presents to the Emergency Department with a 3-day history of severe pain, swelling, and discharge from his right foot. Examination reveals a deep ulcer on the plantar surface with visible bone, surrounding erythema extending 5 cm from the wound edge, and purulent discharge. X-ray shows soft tissue gas and bony destruction. Temperature is 38.6°C, heart rate 104 bpm, and blood pressure 118/72 mmHg. What is the most appropriate initial antibiotic regimen?
A. Oral co-amoxiclav 625 mg three times daily
B. IV flucloxacillin 2 g four times daily plus IV metronidazole 500 mg three times daily
C. IV piperacillin-tazobactam 4.5 g three times daily (Correct Answer)
D. IV teicoplanin 400 mg twice daily plus oral ciprofloxacin 500 mg twice daily
E. Oral doxycycline 100 mg twice daily plus oral metronidazole 400 mg three times daily
Explanation: ***IV piperacillin-tazobactam 4.5 g three times daily***- This patient presents with a **severe diabetic foot infection (DFI)** complicated by **osteomyelitis** (visible bone) and systemic inflammatory response; broad-spectrum IV antibiotics covering **Gram-positives, Gram-negatives, and anaerobes** are essential.- **Piperacillin-tazobactam** provides the necessary empirical coverage for multi-organism infections common in deep diabetic ulcers, including **Pseudomonas** and the gas-forming anaerobes suggested by the X-ray.*Oral co-amoxiclav 625 mg three times daily*- **Oral therapy** is inadequate for a severe infection with **systemic symptoms** (fever, tachycardia) and underlying bone involvement.- While co-amoxiclav has broad activity, the severity and depth of the infection necessitate **intravenous** administration to ensure adequate tissue penetration.*IV flucloxacillin 2 g four times daily plus IV metronidazole 500 mg three times daily*- This regimen lacks sufficient **Gram-negative coverage**, which is required for complex, chronic diabetic foot ulcers.- **Flucloxacillin** is excellent for Staphylococcus, but severe DFIs are often **polymicrobial**, requiring broader agents like piperacillin-tazobactam.*IV teicoplanin 400 mg twice daily plus oral ciprofloxacin 500 mg twice daily*- While this combination offers MRSA and Gram-negative coverage, **ciprofloxacin** provides unreliable **anaerobic coverage**, which is crucial when soft tissue gas is present.- This is generally reserved as a second-line option for patients with **penicillin allergies** rather than first-line empirical therapy.*Oral doxycycline 100 mg twice daily plus oral metronidazole 400 mg three times daily*- This **low-potency oral regimen** is entirely inappropriate for a limb-threatening infection with **radiological evidence of bone destruction**.- Severe infections with **hemodynamic changes** or SIRS criteria require immediate hospitalization and **high-dose parenteral** antibiotics.
Question 210: A 29-year-old woman with no past medical history presents to her GP with a painful red lump on her inner thigh that has been present for 3 days. On examination, there is a 3 cm fluctuant, erythematous swelling with a central punctum. She is apyrexial with no signs of spreading infection. She asks if she needs antibiotics. What is the most appropriate initial management?
A. Prescribe flucloxacillin 500 mg four times daily for 7 days
B. Arrange same-day referral for incision and drainage without antibiotics (Correct Answer)
C. Prescribe warm compress application and safety-netting advice only
D. Prescribe topical fusidic acid three times daily for 5 days
E. Prescribe co-amoxiclav 625 mg three times daily for 5 days
Explanation: ***Arrange same-day referral for incision and drainage without antibiotics***
- The presence of a **fluctuant swelling** with a **central punctum** indicates a localized abscess (e.g., a furuncle), for which **incision and drainage** is the definitive treatment to remove the source of infection.
- In a systemically well patient without signs of **spreading infection** or fever, antibiotics are generally not required, as they poorly penetrate the walled-off abscess cavity.
*Prescribe flucloxacillin 500 mg four times daily for 7 days*
- Antibiotics cannot effectively penetrate a **walled-off abscess cavity**, making medical management alone insufficient for a fluctuant lesion requiring **source control**.
- Prescribing antibiotics for simple abscesses without systemic features contributes to **antimicrobial resistance** and is not recommended by stewardship guidelines.
*Prescribe warm compress application and safety-netting advice only*
- While warm compresses may help early-stage boils, they are inadequate once the lesion is **fluctuant** and 3 cm in size, indicating a mature abscess.
- Delaying drainage of a confirmed abscess can lead to increased pain and potential complications such as **spontaneous rupture** or further spread.
*Prescribe topical fusidic acid three times daily for 5 days*
- **Topical antibiotics** are indicated for superficial infections like **impetigo** but lack the penetration to treat deep-seated dermal abscesses.
- Management of a furuncle requires physical evacuation of the **purulent material**, which a topical cream cannot achieve.
*Prescribe co-amoxiclav 625 mg three times daily for 5 days*
- Co-amoxiclav is an unnecessarily **broad-spectrum** antibiotic for a common skin infection typically caused by *Staphylococcus aureus* in a healthy individual.
- Like flucloxacillin, it is not a substitute for **surgical drainage** when fluctuance is clinically evident, as antibiotics alone are often ineffective for established abscesses.
